Literature DB >> 18239462

Conditional deletion of cyclin-dependent kinase 5 in primary sensory neurons leads to atypical skin lesions.

Brenda Saikkonen1, Tej Kumar Pareek, Nitin Agarwal, Alfredo Molinolo, Martin Kriete, Ashok B Kulkarni.   

Abstract

The key role of Cyclin-dependent kinase 5 (Cdk5) in neuronal function has been well established but understanding of its importance in sensory pathways is in its infancy. Recently we described the important role of Cdk5 in pain signaling. Our studies indicated that conditional deletion of Cdk5 in small sensory neurons causes hypoalgesia. In current study, we identified development of atypical non-healing skin lesions in these mutant mice during the general colony maintenance. Detailed examination of these lesions clearly distinguishes them from ulcerative dermatitis. Here we hypothesize that these skin lesions are due to general sensation loss in these mice as evident from deep skin scratches that turn into unhealed wounds.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18239462      PMCID: PMC3819189          DOI: 10.4161/cc.7.6.5494

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  5 in total

1.  Cyclin-dependent kinase 5 modulates nociceptive signaling through direct phosphorylation of transient receptor potential vanilloid 1.

Authors:  Tej K Pareek; Jason Keller; Sashi Kesavapany; Nitin Agarwal; Rohini Kuner; Harish C Pant; Michael J Iadarola; Roscoe O Brady; Ashok B Kulkarni
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-28       Impact factor: 11.205

2.  Vitamin E as a treatment for ulcerative dermatitis in C57BL/6 mice and strains with a C57BL/6 background.

Authors:  Gregory W Lawson; Akiko Sato; Lynn A Fairbanks; P Timothy Lawson
Journal:  Contemp Top Lab Anim Sci       Date:  2005-05

3.  Cyclin-dependent kinase 5 activity regulates pain signaling.

Authors:  Tej K Pareek; Jason Keller; Sashi Kesavapany; Harish C Pant; Michael J Iadarola; Roscoe O Brady; Ashok B Kulkarni
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-09       Impact factor: 11.205

4.  A retrospective study of idiopathic ulcerative dermatitis in mice with a C57BL/6 background.

Authors:  Robin J Kastenmayer; Michele A Fain; Kathy A Perdue
Journal:  J Am Assoc Lab Anim Sci       Date:  2006-11       Impact factor: 1.232

Review 5.  Cdk5: a new player in pain signaling.

Authors:  Tej K Pareek; Ashok B Kulkarni
Journal:  Cell Cycle       Date:  2006-03-15       Impact factor: 4.534

  5 in total
  6 in total

1.  Molecular Roles of Cdk5 in Pain Signaling.

Authors:  Elias Utreras; Akira Futatsugi; Tej Kumar Pareek; Ashok B Kulkarni
Journal:  Drug Discov Today Ther Strateg       Date:  2009-09

2.  Tumor necrosis factor-alpha regulates cyclin-dependent kinase 5 activity during pain signaling through transcriptional activation of p35.

Authors:  Elias Utreras; Akira Futatsugi; Parvathi Rudrabhatla; Jason Keller; Michael J Iadarola; Harish C Pant; Ashok B Kulkarni
Journal:  J Biol Chem       Date:  2008-12-02       Impact factor: 5.157

3.  Progression of ulcerative dermatitis lesions in C57BL/6Crl mice and the development of a scoring system for dermatitis lesions.

Authors:  Anna L Hampton; Gerald A Hish; Muhammad N Aslam; Edward D Rothman; Ingrid L Bergin; Kathleen A Patterson; Madhav Naik; Tejaswi Paruchuri; James Varani; Howard G Rush
Journal:  J Am Assoc Lab Anim Sci       Date:  2012       Impact factor: 1.232

4.  Cdk5: An Emerging Kinase in Pain Signaling.

Authors:  Tej Kumar Pareek; Lisa Zipp; John J Letterio
Journal:  Brain Disord Ther       Date:  2012-10-03

Review 5.  The role of cyclin-dependent kinase 5 in neuropathic pain.

Authors:  Kimberly Gomez; Tissiana G M Vallecillo; Aubin Moutal; Samantha Perez-Miller; Rodolfo Delgado-Lezama; Ricardo Felix; Rajesh Khanna
Journal:  Pain       Date:  2020-12       Impact factor: 7.926

6.  ERK MAP kinase activation in spinal cord regulates phosphorylation of Cdk5 at serine 159 and contributes to peripheral inflammation induced pain/hypersensitivity.

Authors:  Xiaoqin Zhang; Honghai Zhang; Haijun Shao; Qingsheng Xue; Buwei Yu
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.